Desmoplastic Small Round Cell Tumor (DSRCT) (DBCOND0048978)

Identifiers

Synonyms
Desmoplastic Round Cell Tumor / Desmoplastic Small Round Cell Tumors / Desmoplastic Small Round Cell Tumor / Desmoplastic small round cell tumour / Desmoplastic small round cell tumor (disorder) / Desmoplastic small round cell tumor (morphologic abnormality)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT04008238
Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma PatientsscreeningNot Availablerecruiting
NCT01189643
Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumortreatment0active_not_recruiting
NCT03874455
Tazemetostat Expanded Access Program for Adults With Solid TumorsNot AvailableNot Availableno_longer_available
NCT00563680
QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumorstreatment2completed
NCT04095221
A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcomatreatment1 / 2active_not_recruiting
NCT06625190
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumorstreatment1 / 2not_yet_recruiting
NCT05918640
Lurbinectedin in FET-Fused Tumorstreatment1 / 2recruiting
NCT04530487
Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adultstreatment2terminated
NCT06277154
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcomatreatment2not_yet_recruiting
NCT04901806
Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid TumorsNo drug interventionstreatment1terminated
NCT02982941
Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumorstreatment1completed
NCT03967834
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma GroupNo drug interventionsotherNot Availablerecruiting
NCT02982486
A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinomatreatment2unknown_status
NCT00436657
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancertreatment1completed
NCT04897321
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)treatment1recruiting
NCT04483778
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adultstreatment1active_not_recruiting
NCT06456359
Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumortreatment2not_yet_recruiting
NCT04145349
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumortreatment1 / 2active_not_recruiting
NCT03600649
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomastreatment1active_not_recruiting
NCT01125449
Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Diseasetreatment2suspended
NCT04022213
A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneumtreatment2recruiting
NCT05266196
A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)treatment1 / 2enrolling_by_invitation
NCT04690374
Registry to Collect Health Information About Desmoplastic Small Round Cell TumorNo drug interventionsNot AvailableNot Availablerecruiting
NCT01946529
Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumorstreatment2active_not_recruiting
NCT02834169
French National Registry of Rare Peritoneal Surface MalignanciesNo drug interventionsNot AvailableNot Availableunknown_status
NCT03618381
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsNo drug interventionstreatment1recruiting